Your browser doesn't support javascript.
loading
The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
Romanò, Luisa; Paladini, Sara; Tagliacarne, Catia; Zappa, Alessandra; Zanetti, Alessandro Remo.
Affiliation
  • Romanò L; Department of Public Health - Microbiology - Virology, University of Milan, Via C. Pascal 36, 20133 Milano, Italy.
Vaccine ; 27(25-26): 3439-42, 2009 May 26.
Article in En | MEDLINE | ID: mdl-19200848
The morbidity and mortality rates of viral hepatitis A, B and Delta have dramatically dropped in Italy during the last decades. Thanks to the general improvements in hygiene and sanitation, hepatitis A has shifted from a high to an intermediate/low endemicity status. Vaccination against hepatitis A is recommended to people at increased risk, including travellers to endemic areas, military personnel and individuals at occupational risk. The implementation of universal anti-hepatitis B vaccination of infants and adolescents has resulted in a dramatic decline in disease burden and in the carrier rate. An additional benefit of hepatitis B vaccination is that hepatitis Delta has also substantially declined.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis D / Vaccination / Hepatitis B Vaccines / Hepatitis A Vaccines / Hepatitis A / Hepatitis B Type of study: Screening_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Vaccine Year: 2009 Document type: Article Affiliation country: Italy Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis D / Vaccination / Hepatitis B Vaccines / Hepatitis A Vaccines / Hepatitis A / Hepatitis B Type of study: Screening_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Vaccine Year: 2009 Document type: Article Affiliation country: Italy Country of publication: Netherlands